01Growth & Commercial Strategy
Strategies that end
in commitments.
For organizations under pressure to add lines of business, enter new markets, or convert clinical capability into revenue.
The work
We close the gap between the board deck and the first signed contract.
Most healthcare growth strategies fail in the execution gap between the board deck and the first signed contract. We have built and sold the products, structured the payer and provider partnerships, and run the P&Ls that growth strategies are supposed to produce. That experience shapes how we work: we pressure-test the thesis against what buyers actually buy, what regulators will accept, and what your operating team can credibly deliver in the next four quarters.
Where we work
Four shapes of engagement.
New line of business
Virtual-first sub-specialty practices, hospital@home, RPM and RTM programs, employer-sponsored direct primary care, Specialty ACO participation. Designed and launched, not just whitepapered.
Commercial partnerships
Structuring deals between payers, providers, retail, and pharma. Joint bids, risk-sharing arrangements, distribution agreements. We have sat on every side of the table.
Pricing, packaging, GTM
For healthcare technology and services companies selling into providers, plans, and employers. What the buyer actually buys, at what price, with what proof.
M&A and PE portfolio support
Diligence on the operating thesis. Post-close integration of clinical, technology, and revenue functions. Honest reads on which platforms can absorb the next add-on and which cannot.
What changes
You stop having strategy conversations that don’t end in commitments. The roadmap names the buyer, the price, the regulatory path, and the team that owns it. Your operators know what they are accountable for on Monday morning.
Call us if
Any of these are true.
- ◆The growth strategy has been written more than once and still hasn't moved.
- ◆A PE thesis depends on a clinical or commercial capability the platform doesn't have yet.
- ◆You are entering a new buyer segment (employer, payer, or provider) and need someone who has sold there.
- ◆You need a sober view on whether to build, partner, or acquire the missing piece.
Operator proof
Done before, at scale.
Selected outcomes from prior operating roles. Client names withheld.
600K
Members covered by a joint commercial bid structured with a regional payer
40%
In-person visit conversion to virtual across a $1.2B care delivery business
Delivery
Delivered through Cara Embedded.
A forward deployed engineer and a project manager sitting with your team. Running on the Cara platform when it accelerates the outcome. Platform optional.